157.42 USD
-19.64
11.09%
At close Feb 14, 4:00 PM EST
After hours
157.34
-0.08
0.05%
1 day
-11.09%
5 days
-9.31%
1 month
-2.83%
3 months
1.98%
6 months
5.74%
Year to date
5.07%
1 year
27.56%
5 years
83.09%
10 years
116.30%
 

About: DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

Employees: 76,000

0
Funds holding %
of 6,831 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

90% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 49

14% more capital invested

Capital invested by funds: $10.8B [Q2] → $12.2B (+$1.48B) [Q3]

7% more funds holding

Funds holding: 550 [Q2] → 589 (+39) [Q3]

3.3% less ownership

Funds ownership: 88.69% [Q2] → 85.38% (-3.3%) [Q3]

17% less repeat investments, than reductions

Existing positions increased: 180 | Existing positions reduced: 218

20% less funds holding in top 10

Funds holding in top 10: 5 [Q2] → 4 (-1) [Q3]

22% less call options, than puts

Call options by funds: $243M | Put options by funds: $313M

Research analyst outlook

We haven’t received any recent analyst ratings for DVA.

Financial journalist opinion

Based on 21 articles about DVA published over the past 30 days

Negative
The Motley Fool
2 days ago
Why DaVita Inc Stock Is Plummeting Today
Shares of DaVita Inc (DVA -11.09%) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day.
Why DaVita Inc Stock Is Plummeting Today
Negative
Market Watch
2 days ago
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.
DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.
Negative
Finbold
2 days ago
Here's why Warren Buffett dumped $31 million worth of this stock
Warren Buffett, the ‘Oracle of Omaha', managed to attain a roughly $142 billion net worth by consistently outperforming the markets. The Berkshire Hathaway (NYSE: BRK.B) chief executive officer (CEO) and chairman did so by utilizing a careful, level-headed approach to investing.
Here's why Warren Buffett dumped $31 million worth of this stock
Negative
CNBC
2 days ago
Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance
DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.
Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance
Neutral
Seeking Alpha
3 days ago
DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript
DaVita Inc. (NYSE:DVA ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Joanna Gajuk - Bank of America AJ Rice - UBS Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good evening. My name is Michelle, and I will be your conference facilitator today.
DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript
Negative
Reuters
3 days ago
Berkshire sells some DaVita shares, cuts stake to 45%
Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 billion.
Berkshire sells some DaVita shares, cuts stake to 45%
Positive
Zacks Investment Research
3 days ago
DaVita HealthCare (DVA) Beats Q4 Earnings and Revenue Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2.24 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $1.87 per share a year ago.
DaVita HealthCare (DVA) Beats Q4 Earnings and Revenue Estimates
Negative
Reuters
3 days ago
DaVita forecasts 2025 profit below estimates, shares plummet
Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.
DaVita forecasts 2025 profit below estimates, shares plummet
Neutral
PRNewsWire
3 days ago
DaVita Inc. 4th Quarter 2024 Results
DENVER , Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range," said Javier Rodriquez, CEO of DaVita Inc. "As we embark on 2025, when we will be celebrating the 25th anniversary of DaVita, we look forward to continuing our efforts to improve clinical outcomes, enhance quality of life for our patients and teammates, and be a force for positive change in the healthcare system.
DaVita Inc. 4th Quarter 2024 Results
Positive
Zacks Investment Research
4 days ago
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?
Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?
Charts implemented using Lightweight Charts™